by PEIBioAlliance | Aug 14, 2018 | Clients, News
Emergence client, MicroSintesis, Inc., has announced that it has received registration of its new probiotic strain, La-21, in humans. Microsintesis is a life sciences company developing a novel platform of anti-infective and health products using patented probiotic...
by PEIBioAlliance | Aug 14, 2018 | Clients, News
To help launch its new products, Emergence client, Somru BioScience of Charlottetown, PEI, is raising a $7 million round of funding, and already has commitments for almost half this amount from government funders, writes Entrevestor.View the full story here! During a...
by PEIBioAlliance | Aug 14, 2018 | Clients, News
Emergence client, Charlottetown, PEI-based Somru BioScience, will receive over $4 million in federal and provincial funding to support its latest research and development project. You can read the original story here! Federal Minister of Innovation, Science...
by PEIBioAlliance | Aug 14, 2018 | Clients, News
Emergence client, Tieös Pharmaceuticals, has engaged in a joint initiative with the Lady Davis Institute (LDI) to perform preclinical validation of their lead metabolic compounds, currently under development. Tieös is a next-generation biotech company focused on...
by PEIBioAlliance | Aug 14, 2018 | Clients, News, Partner
In an August 2018 article entitled “Recent Developments in Regulation of Software as a Medical Device”, our friends Andrea Berenbaum and Noel Courage from Emergence Partner, boutique IP law firm Bereskin & Parr, write: “The digital health...
